课题基金 / 基金详情

Administrative Core

Administrative Core
行政核心
批准号:
8637921
负责人:
Kevin V Morris
金额:
$12.82万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Kevin V Morris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The administrative core will be responsible for all administration of this program. The program proposed here contains 3 independent yet linked projects and 2 scientific cores that will develop 3 different strategies to deliver non-coding RNAs capable of transcriptionally suppressing and directing the excising of HIV-1 or the CCR5 chemokine co-receptor to either HIV-1 infected cells or those immune cells targeted for infection by HIV-1. The administrative core will function by: Overseeing the fiscal, administrative, and legal responsibilities for the entire program; fostering interactions between the different investigators and their respective projects; and assuming responsibility for confirming that all research is conducted in an optimal and ethical manner. As such the role of the administrative core is integral to the success of this program. The specific aims of the administrative core are: (1) Coordinate administrative and fiscal requirements of the program. (2) Supervise and foster the scientific progress of the program. (3) Oversee the dissemination and sharing of the results from each project within the program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted transcriptional activation of HIV
Activating cystic fibrosis transmembrane conductance regulator: the therapeutic potential of RNA directed gene activation
Activating cystic fibrosis transmembrance conductance regulator: the therapeutic potential of RNA directed gene activation
  • 批准号:
    8855170
  • 项目类别:
  • 资助金额:
    $41.37万
  • 财政年份:
    2015
  • 负责人:
    Kevin V Morris
  • 依托单位:
Targeted inhibition of HIV-1 latency
  • 批准号:
    8895833
  • 项目类别:
  • 资助金额:
    $55.62万
  • 财政年份:
    2014
  • 负责人:
    Kevin V Morris
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: